enGene
enGene is a developer of a mucosal immunotherapy platform designed to treat inflammatory bowel disease and diabetes. The company's mucosal immunotherapy platform has developed a flexible nucleotide delivery technology targeting mucosal tissues to treat numerous prevalent, chronic diseases via the induction or suppression of protein expression levels, enabling physicians and doctors to regenerate physiologic, meal-regulated insulin secretion from the gut of subjects with diabetes.
Tech Stack (2 technologies)
Frequently Asked Questions
What technologies does enGene use?+
enGene uses 2 technologies including Google Font API, Nginx.
What industry is enGene in?+
enGene operates in the Biotechnology industry.
Where is enGene based?+
enGene is headquartered in Canada.
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026